QuidelOrtho Corporation QDEL Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| China | $63.5M-15.3% | $91.7M+5.5% | $84.6M+5.2% | $83.4M+2.2% | $75M-1.4% | |
| EMEA | $92.5M+4.0% | $92.7M+7.9% | $91.8M+9.3% | $87.3M+7.6% | $88.9M+4.8% | |
| JPAC | $70M+2.8% | —— | —— | —— | $68.1M-2.5% | |
| Latin America | $64.9M+20.0% | —— | —— | —— | $54.1M-2.9% | |
| North America | $328.9M-19.1% | $390.1M-2.4% | $381.4M-12.6% | $310.7M-11.3% | $406.7M-6.3% | |
| Segment Information, Other Income (Expense) by Business | ||||||
| China | $200K— | $100K— | -$100K-110% | $1.1M-21.4% | $0— | |
| EMEA | -$800K+50.0% | -$700K+22.2% | -$900K-28.6% | -$800K-214% | -$1.6M-220% | |
| JPAC | $700K— | —— | —— | —— | $0-100% | |
| Latin America | $100K-50.0% | —— | —— | —— | $200K-46.7% | |
| North America | -$200K— | -$200K-300% | -$100K— | $0-100% | $0+100% | |
| Segment Adjusted EBITDA by Business | ||||||
| China | $20.5M-30.0% | $33M+3.4% | $36.8M0.0% | $42.1M+17.9% | $29.3M+12.3% | |
| EMEA | $20.1M+21.8% | $23.4M+136% | $24.4M+89.1% | $18.3M+51.2% | $16.5M+42.2% | |
| JPAC | $16.5M-6.3% | —— | —— | —— | $17.6M+0.7% | |
| Latin America | $15.8M+31.7% | —— | —— | —— | $12M-24.5% | |
| North America | $169.4M-27.7% | $202.2M-8.9% | $210.8M-15.0% | $159.7M-14.0% | $234.3M-1.0% | |
| Cost of sales, excluding amortization of intangibles by Business | ||||||
| China | $32M-6.4% | $46.2M+10.3% | $36.4M+12.7% | $30.8M-12.7% | $34.2M-11.2% | |
| EMEA | $44.6M-5.7% | $43.5M-9.6% | $41.2M-5.5% | $43.9M+1.2% | $47.3M+6.5% | |
| JPAC | $41.5M+9.5% | —— | —— | —— | $37.9M-1.6% | |
| Latin America | $36.7M+14.3% | —— | —— | —— | $32.1M+9.6% | |
| North America | $114.5M-10.8% | $144.1M+8.9% | $129M-11.4% | $110.6M-8.9% | $128.4M-13.1% | |
| Selling, marketing and administrative by Business | ||||||
| China | $10.5M-0.9% | $11.9M0.0% | $10.6M-6.2% | $10.8M-1.8% | $10.6M+1.9% | |
| EMEA | $26.6M+16.2% | $24.3M-7.3% | $24.6M-6.1% | $23.6M-8.2% | $22.9M-17.3% | |
| JPAC | $12.4M+1.6% | —— | —— | —— | $12.2M-10.6% | |
| Latin America | $12M+22.4% | —— | —— | —— | $9.8M-6.7% | |
| North America | $44.4M+1.8% | $43.2M-4.2% | $41.1M-2.6% | $40M-7.4% | $43.6M-11.2% | |
| R&D by Business | ||||||
| China | $700K-22.2% | $700K-41.7% | $700K-30.0% | $800K-20.0% | $900K-18.2% | |
| EMEA | $400K-33.3% | $800K0.0% | $700K+16.7% | $700K+16.7% | $600K0.0% | |
| JPAC | $300K-25.0% | —— | —— | —— | $400K+6.7% | |
| Latin America | $500K+25.0% | —— | —— | —— | $400K0.0% | |
| North America | $400K0.0% | $400K0.0% | $400K0.0% | $400K0.0% | $400K0.0% | |
| Percentage of risk concentration by Product | ||||||
| Respiratory | 11%-6.0pp | 1%0.0pp | 16%-7.0pp | 8%-1.0pp | 17%-2.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does QuidelOrtho Corporation break its business down?
- QuidelOrtho Corporation (QDEL) reports total revenues by business across 5 parts — China, EMEA, JPAC, Latin America and North America. Each is extracted from the segment footnotes and tracked over time.
- Where does QuidelOrtho Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in QuidelOrtho Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
